|
Global Point-of-Care Testing Market Expected to Reach $17.8 Billion by 2014 Tue Oct 13, 2009 1:19pm HUNTINGTON BEACH, Calif.--(Business Wire)--
According to a new report distributed by Life Science Intelligence (LSI), the
global point-of-care (POC) testing market will experience dramatic growth from
$12.8 billion in 2008 to $17.8 billion by 2014. The new report, Worldwide
Markets and Emerging Technologies for Point-of-Care Testing, provides a global
analysis of the patients, procedures, technologies, and companies driving growth
and innovation in the POC testing market.
The report segments the market into three primary areas: hospital bedside
testing products; home and self-testing products; and physician's office lab
products. Each of these areas is further segmented by product and geography with
detailed share-by-supplier information. Various factors driving growth are
covered, including: the demands of physicians for more efficient approaches to
the delivery of care; demands for faster access to diagnostic test results to
optimize patient outcomes in emergency and critical care settings; the
development of advanced analytical technologies, including high-sensitivity
assays suitable for POC use, as well as microfluidics technologies that enable
highly sophisticated assays to be performed at the bedside by non-laboratory
personnel, with accuracy equivalent to that achieved in the central laboratory;
and advanced computer and communications technologies that allow POC testing to
be managed as effectively as tests performed in the central lab.
The study was developed using multiple research methodologies and secondary and
primary research, including 238 interviews with leading pathologists and
laboratory directors; researchers and technical experts; and company presidents,
marketing executives, and business development executives. The report contains
308 pages, 130 exhibits, and coverage of over 250 competitors, including:
Abaxis, Abbott Laboratories, Accumetrics, Arkray, Axis-Shield, Bayer Diabetes
Care, Beckman Coulter, Biosite, Cepheid, Cholestech, Dexcom, Genzyme, Helena
Labs, Hemocue, HemoSense, Home Diagnostics, IDEXX Laboratories/OPTI Medical,
International Technidyne/Thoratec, Menarini Diagnostics, Nanogen/ELITech Group,
OraSure Technologies, Ortho Clinical Diagnostics/LifeScan, Phamatech, QBC
Diagnostics/The Drucker Company, Quidel, Radiometer, Response Biomedical, Roche
Diagnostics, Siemens Diagnostics, and Trinity Biotech.
Immediate access to the Table of Contents and Company Listing for this report is
available at: lifescienceintelligence.com/market-reports-page.php?id=IL529
About Life Science Intelligence (LSI)
LSI delivers high-quality market data and competitive intelligence to medical
technology executives, entrepreneurs, and investors. LSI produces the EMT
(Emerging Medical Technologies) Database, EMT (Emerging Medical
Technologies)TMSpotlight events, medtech market reports, and provides global
custom research services. www.LSintelligence.com
http://www.reuters.com/article/pressRelease/...13-Oct-2009+BW20091013
|
Thread abonnieren
